Filing Details

Accession Number:
0001104659-25-014354
Form Type:
13G Filing
Publication Date:
2025-02-13 19:00:00
Filed By:
Van Herk Investments B.V.
Company:
Proqr Therapeutics N.v. (NASDAQ:PRQR)
Filing Date:
2025-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Van Herk Investments B.V. 0 11,461,995 10.9%
Van Herk Investments THI B.V. 0 11,461,995 10.9%
Van Herk Private Equity Investments B.V. 0 11,461,995 10.9%
Stichting Administratiekantoor Penulata 0 11,461,995 10.9%
Van Herk Management Services B.V. 0 11,461,995 10.9%
Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V. 0 11,461,995 10.9%
A. van Herk Holding B.V. 0 11,461,995 10.9%
Stichting Administratiekantoor Abchrys 0 11,461,995 10.9%
Adrianus van Herk 0 11,461,995 10.9%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Van Herk Investments B.V.
 
Signature:/s/ Erik G.A. Esveld
Name/Title:Erik G.A. Esveld/Attorney-In-Fact*
Date:02/14/2025
 
Van Herk Investments THI B.V.
 
Signature:/s/ Erik G.A. Esveld
Name/Title:Erik G.A. Esveld/Attorney-In-Fact*
Date:02/14/2025
 
Van Herk Private Equity Investments B.V.
 
Signature:/s/ Erik G.A. Esveld
Name/Title:Erik G.A. Esveld/Attorney-In-Fact*
Date:02/14/2025
 
Stichting Administratiekantoor Penulata
 
Signature:/s/ Erik G.A. Esveld
Name/Title:Erik G.A. Esveld/Attorney-In-Fact*
Date:02/14/2025
 
Van Herk Management Services B.V.
 
Signature:/s/ Erik G.A. Esveld
Name/Title:Erik G.A. Esveld/Attorney-In-Fact*
Date:02/14/2025
 
Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V.
 
Signature:/s/ Erik G.A. Esveld
Name/Title:Erik G.A. Esveld/Attorney-In-Fact*
Date:02/14/2025
 
A. van Herk Holding B.V.
 
Signature:/s/ Erik G.A. Esveld
Name/Title:Erik G.A. Esveld/Attorney-In-Fact*
Date:02/14/2025
 
Stichting Administratiekantoor Abchrys
 
Signature:/s/ Erik G.A. Esveld
Name/Title:Erik G.A. Esveld/Attorney-In-Fact*
Date:02/14/2025
 
Adrianus van Herk
 
Signature:/s/ Erik G.A. Esveld
Name/Title:Erik G.A. Esveld/Attorney-In-Fact*
Date:02/14/2025

Comments accompanying signature:  * Pursuant to a Power of Attorney, dated as of September 16, 2019, by and among the Reporting Persons.
Exhibit Information

99.1 Joint Filing Agreement, dated February 14, 2025, by and among the Reporting Persons, as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended. 99.2 Power of Attorney, dated as of September 16, 2019, by and among the Reporting Persons, incorporated by reference herein by reference to Exhibit 99.2 to Amendment No. 3 to Schedule 13G filed by the Reporting Persons on September 17, 2019 with respect to Zealand Pharma A/S (File No. 001-38178).